Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Surrogate markers for cardiovascular disease: structural markers.
Mancini GB, Dahlöf B, Díez J. Mancini GB, et al. Among authors: dahlof b. Circulation. 2004 Jun 29;109(25 Suppl 1):IV22-30. doi: 10.1161/01.CIR.0000133443.77237.2f. Circulation. 2004. PMID: 15226248 Review. No abstract available.
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, Sommerfeld M, Kemnitz UR, Curato C, Namsolleck P, Tschöpe C, Hallberg A, Alterman M, Hucko T, Paetsch I, Dietrich T, Schnackenburg B, Graf K, Dahlöf B, Kintscher U, Unger T, Steckelings UM. Kaschina E, et al. Among authors: dahlof b. Circulation. 2008 Dec 9;118(24):2523-32. doi: 10.1161/CIRCULATIONAHA.108.784868. Epub 2008 Nov 24. Circulation. 2008. PMID: 19029468
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial.
Ciulla MM, Paliotti R, Esposito A, Dìez J, López B, Dahlöf B, Nicholls MG, Smith RD, Gilles L, Magrini F, Zanchetti A. Ciulla MM, et al. Among authors: dahlof b. Circulation. 2004 Aug 3;110(5):552-7. doi: 10.1161/01.CIR.0000137118.47943.5C. Epub 2004 Jul 26. Circulation. 2004. PMID: 15277331 Clinical Trial.
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators. Solomon SD, et al. Among authors: dahlof b. Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19. Circulation. 2009. PMID: 19153265 Clinical Trial.
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB. de Simone G, et al. Among authors: dahlof b. Circulation. 2005 Apr 19;111(15):1924-31. doi: 10.1161/01.CIR.0000161799.91577.0A. Circulation. 2005. PMID: 15837945 Clinical Trial.
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Devereux RB, et al. Among authors: dahlof b. Circulation. 2004 Sep 14;110(11):1456-62. doi: 10.1161/01.CIR.0000141573.44737.5A. Epub 2004 Aug 23. Circulation. 2004. PMID: 15326072 Clinical Trial.
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B; LIFE Study Investigators. Okin PM, et al. Among authors: dahlof b. Circulation. 2006 Jan 3;113(1):67-73. doi: 10.1161/CIRCULATIONAHA.105.569491. Epub 2005 Dec 19. Circulation. 2006. PMID: 16365195
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K. Wachtell K, et al. Among authors: dahlof b. Circulation. 2007 Aug 14;116(7):700-5. doi: 10.1161/CIRCULATIONAHA.106.666594. Epub 2007 Jul 30. Circulation. 2007. PMID: 17664372 Clinical Trial.
392 results